Form 4 for CGON CG Oncology, Inc.
Accepted 2026-03-13 00:00:00 ET · period of report 2026-03-12 · accession 0002007101-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-13 | 2026-03-12 | CGON | Kuan Arthur | CEO, Dir | F - Tax | $60.15 | -1,847 | 198.9K | -0.9% | -$111.1K |
| D | 2026-03-13 | 2026-03-12 | CGON | Kuan Arthur | CEO, Dir | M - OptEx | $1.72 | +64.6K | 200.8K | +47% | +$111.1K |
| D | 2026-03-13 | 2026-03-12 | CGON | Kuan Arthur | CEO, Dir | M - OptEx | $0.00 | -64.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-12 | F | D | 1,847 | $60.15 | 198,916 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-12 | M | A | 64,612 | $1.72 | 200,763 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2026-03-12 | M | D | 64,612 | $0.00 | 0 | D | $1.72 · — to 2031-04-18 | 64,612 Common Stock | (F2) The stock option is currently vested and exercisable. |